| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Evarts EV, Landau W, Frey... |
Some effects of lysergic acid diethylamide and bufotenine on electrica... |
Amer. J. Physiol. |
1955 |
| Rey JC |
Psicósis lisérgica. (LSD psychosis) |
Rev. psiquiatr. |
1957 |
| Hofmann A, Frey A, Ott H,... |
Konstitutionsaufklärung und Synthese von Psilocybin |
Experientia |
1958 |
| Hofmann A, Frey A, Ott H,... |
Détermination de la Structure et Synthèse de la Psilocybine |
Les champignons hall... |
1958 |
| Hofmann A, Heim R, Brack ... |
Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen... |
Helv. chim. Acta |
1959 |
| Burton RM, Kaplan NO, Gol... |
Interaction of nicotinamide with resperpine and chorpromazine. III. So... |
Arch. int. Pharmacod... |
1960 |
| PA Stadler, F Troxler, AJ... |
Selektive Reduktions- und oxydationsreaktionen an Lysergsaure-Derivate... |
Helv. Chim. Acta |
1964 |
| Fontana AE, Reynoso R |
Individual psychotherapy with hallucinogens |
Psychotherapy with H... |
1965 |
| Godfrey KE |
The metamorphosis of an LSD psychotherapist |
2nd International Co... |
1967 |
| Godfrey KE |
Psychedelic drugs as therapeutic agents |
Psychedelic drugs. |
1969 |
| Corey MJ, Andrews JC, McL... |
Chromosome studies on patients (in vivo) and cells (in vitro) treated ... |
New Engl. J. Med. |
1970 |
| Bailey K, Grey A |
A Conformational Study of Lysergic Acid and iso-Lysergic Acid Dialkyla... |
Can J Chem |
1972 |
| Despaux N, Duprey F, Bohu... |
Les radioimmunoessais. Leur application en toxicologie |
Pathologie Biologie |
1976 |
| Friedman H, Carey RJ |
Acute And Chronic Single Dose Effects Of LSD 25 On Visual Discriminati... |
Pharm. Biochem. Beha... |
1976 |
| Friedman H, Carey RJ |
Long-Term Effects of LSD-25 on Easy and Hard Visual Discrimination in ... |
Pharmacol. Biochem. ... |
1978 |
| Ardrey RE, Moffat AC |
A compilation of analytical data for the identification of lysergide a... |
J. forens. Sci. Soc. |
1979 |
| McCall RB, Humphrey SJ |
Involvement of Serotonin in the Central Regulation of Blood Pressure: ... |
J. Pharmacol. Exp. T... |
1982 |
| Perez-Reyes M, Wall ME |
Presence of delta9-tetrahydrocannabinol in human milk |
N Engl J Med |
1982 |
| Mccall RB, Schuette MR, H... |
Evidence for a Central Sympathoexcitatory Action of Alpha-2 Adrenergic... |
The Journal Of Pharm... |
1983 |
| Wall ME, Sadler BM, Brine... |
Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol ... |
Clin Pharmacol Ther |
1983 |
| Nebes RD, Reynolds CF, Ho... |
The effect of vasopressin on memory in the healthy elderly |
Psychiatry Res |
1984 |
| Schachter M, Godfrey PP, ... |
Serotonergic Agonists Stimulate Inositol Lipid Metabolism In Rabbit Pl... |
Life Sciences |
1985 |
| Tennes K, Avitable N, Bla... |
Marijuana: prenatal and postnatal exposure in the human |
NIDA Res Monogr |
1985 |
| Reynolds PC, Jindrich EJ |
A mescaline associated fatality |
J Anal Toxicol |
1985 |
| Perez-Reyes M, Burstein S... |
Antagonism of marihuana effects by indomethacin in humans |
Life Sci |
1991 |
| Davis RA, Stiles MF, deBe... |
Dietary nicotine: a source of urinary cotinine |
Food Chem Toxicol |
1991 |
| Henry JA, Jeffreys KJ, Da... |
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy') |
Lancet |
1992 |
| Schmidt CJ, Black CK, Tay... |
The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-... |
Eur J Pharmacol |
1992 |
| Schmidt CJ, Kehne JH, Car... |
Contribution of serotonin neurotoxins to understanding psychiatric dis... |
International Clinic... |
1993 |
| Palfreyman MG, Schmidt CJ... |
Electrophysiological, biochemical and behavioral evidence for 5-HT2 an... |
Psychopharmacology (... |
1993 |
| Capurro A, Reyes-Paroda M... |
Aggressive Behavior and Jamming Avoidance Response in Weakly Electric ... |
Comp Biochem Physiol |
1997 |
| Mueller PD, Korey WS |
Death by 'ecstasy': the serotonin syndrome? |
Ann Emerg Med |
1998 |
| Meltzer CC, Smith G, DeKo... |
Serotonin in Aging, Late-Life Depression, and Alzheimer’s Disease: The... |
Neuropsychopharmacol... |
1998 |
| Varela-Rey M, Montiel-Dua... |
3,4-methylenedioxymethamphetamine ('Ecstasy') stimulates the expressio... |
Biochem Biophys Res ... |
1999 |
| Acuña-Castillo, C. Scorza... |
ALEPH-2, a suspected anxiolytic and putativehallucinogenic phenylisopr... |
Life Sciences |
2000 |
| Wax P, Reynolds M |
Just a click away: student Internet surfing for recreational drug info... |
Journal of Toxicolog... |
2000 |
| Todorovic SM, Jevtovic-To... |
Ca(v)3.2 channel is a molecular substrate for inhibition of T-type cal... |
Mol Pharmacol |
2001 |
| de Boer D, Bosman IJ, Hid... |
Piperazine-like compounds: a new group of designer drugs-of-abuse on t... |
Forensic Sci Int |
2001 |
| Carmo H, de Boer D, Remiã... |
Identification of 4-methylthioamphetamine and some of its metabolites ... |
J Anal Toxicol |
2002 |
| Campo JV, McNabb J, Perel... |
Kava-induced fulminant hepatic failure |
J Am Acad Child Adol... |
2002 |
| Gobbi M, Moia M, Pirona L... |
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neur... |
J Neurochem |
2002 |
| Montiel-Duarte C, Varela-... |
3,4-Methylenedioxymethamphetamine ("Ecstasy") induces apoptosis of cul... |
Biochim Biophys Acta |
2002 |
| Morral AR, McCaffrey DF, ... |
Reassessing the marijuana gateway effect |
Addiction |
2002 |
| Carmo H, Remião F, Carval... |
4-Methylthioamphetamine-induced hyperthermia in mice: influence of ser... |
Toxicol Appl Pharmac... |
2003 |
| Pardo Rey C, Yebra M, Bor... |
Irreversible coma, ergotamine, and ritonavir |
Clin Infect Dis |
2003 |
| Carmo H, Hengstler JG, de... |
Comparative metabolism of the designer drug 4-methylthioamphetamine by... |
Naunyn Schmiedebergs... |
2004 |
| Carmo H, de Boer D, Remiã... |
Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine 2C... |
J Chromatogr B Analy... |
2004 |
| Carmo H, Hengstler JG, de... |
Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine 2C-B: analys... |
Toxicology |
2005 |
| Gallardo-Godoy A, Fierro ... |
Sulfur-substituted alpha-alkyl phenethylamines as selective and revers... |
J Med Chem |
2005 |
| Morris S, Humphreys D, Re... |
Myth, marula, and elephant: an assessment of voluntary ethanol intoxic... |
Physiol Biochem Zool |
2006 |
| Furey ML, Drevets WC |
Antidepressant efficacy of the antimuscarinic drug scopolamine: a rand... |
Arch Gen Psychiatry |
2006 |
| Shields LB, Hunsaker Iii ... |
Methadone toxicity fatalities: a review of medical examiner cases in a... |
J Forensic Sci |
2007 |
| Karila L, Reynaud M |
[Mephedrone: A designer drug legally available on the Web] |
Presse Med |
2010 |
| Murnane KS, Fantegrossi W... |
Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetami... |
J Pharmacol Exp Ther |
2010 |
| Karila L, Reynaud M |
GHB and synthetic cathinones: clinical effects and potential consequen... |
Drug Test Anal |
2010 |
| Freyer CW, Peters M |
Palpable Purpura Complicated by Streptococcal Toxic Shock Syndrome Res... |
Pharmacotherapy |
2012 |
| Vandrey R, Stitzer ML, Mi... |
The dose effects of short-term dronabinol (oral THC) maintenance in da... |
Drug Alcohol Depend |
2013 |
| Ellis JS, Zarate CA, Luck... |
Antidepressant treatment history as a predictor of response to scopola... |
Journal of Affective... |
2014 |
| McIntyre IM, Trochta A, G... |
A Fatality Related to Two Novel Hallucinogenic Compounds: 4-Methoxyphe... |
J Anal Toxicol |
2015 |
| Paul MJ, Chisolm MS, John... |
Assessing the Validity of Online Drug Forums as a Source for Estimatin... |
J Addict Med |
2016 |
| Martial C, Cassol H, Char... |
Neurochemical models of near-death experiences: a large-scale study ba... |
Conscious Cogn |
2019 |
